BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,594,270 | -3.5% | 9,891,000 | -2.3% | 0.26% | -5.0% |
| Q2 2023 | $9,943,520 | -7.3% | 10,123,000 | -3.1% | 0.28% | -5.4% |
| Q1 2023 | $10,721,491 | -5.1% | 10,450,000 | -1.9% | 0.29% | +2.1% |
| Q4 2022 | $11,300,723 | +2.1% | 10,648,000 | -4.7% | 0.29% | +2.9% |
| Q3 2022 | $11,068,000 | -2.1% | 11,171,000 | -2.2% | 0.28% | +2.2% |
| Q2 2022 | $11,304,000 | -4.3% | 11,419,000 | -3.4% | 0.27% | +163.5% |
| Q1 2022 | $11,816,000 | -62.5% | 11,822,000 | -60.7% | 0.10% | -60.2% |
| Q4 2021 | $31,477,000 | -39.0% | 30,060,000 | -40.3% | 0.26% | -46.3% |
| Q3 2021 | $51,598,000 | -17.7% | 50,335,000 | -16.6% | 0.49% | -17.5% |
| Q2 2021 | $62,692,000 | -24.1% | 60,380,000 | -25.9% | 0.59% | -2.2% |
| Q1 2021 | $82,605,000 | +16.4% | 81,462,000 | +23.4% | 0.60% | +23.1% |
| Q4 2020 | $70,980,000 | +1.6% | 66,018,000 | -0.6% | 0.49% | +3.2% |
| Q3 2020 | $69,871,000 | -14.1% | 66,439,000 | -0.0% | 0.47% | -27.0% |
| Q2 2020 | $81,353,000 | +16.7% | 66,447,000 | +0.1% | 0.65% | +0.6% |
| Q1 2020 | $69,741,000 | -0.7% | 66,407,000 | +0.1% | 0.64% | +33.3% |
| Q4 2019 | $70,268,000 | -28.2% | 66,367,000 | -33.2% | 0.48% | -18.9% |
| Q3 2019 | $97,880,000 | +62.1% | 99,336,000 | +71.2% | 0.60% | +44.9% |
| Q2 2019 | $60,371,000 | +8.2% | 58,028,000 | +6.6% | 0.41% | +1.7% |
| Q1 2019 | $55,806,000 | +4.9% | 54,426,000 | +2.0% | 0.40% | -6.2% |
| Q4 2018 | $53,195,000 | -6.7% | 53,374,000 | -0.0% | 0.43% | -0.7% |
| Q3 2018 | $57,017,000 | +27.4% | 53,388,000 | +20.8% | 0.44% | +40.3% |
| Q2 2018 | $44,757,000 | – | 44,195,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |